Trial Information

Summary: Pediatric Allergy study for children 6-11 years of age

Health Sciences Research Center is conducting a research study to evaluate an investigational drug for children 6 to 11 years of age. The patients in this study have moderate to severe asthma and continue to demonstrate inadequate control. The investigational drug or placebo is an injection administered every two to four weeks, added onto existing inhaled or systemic steroid therapy.

You may participate in this study if you:

• Are at least six years of age but under twelve years of age
• Have moderate to severe persistent asthma for at least one year
• Have inadequate symptom control of asthma
• Have a past medical history of asthma exacerbations requiring more medication or treatment in hospital or emergency room
• Are receiving inhaled corticosteroids

You cannot participate in this study if you:

• Have a history of severe food or drug related anaphylactic reaction
• Have active lung disease other than allergic asthma
• Have been treated with investigational drug within the past 30 days

Additional Information:

• All study visits, study medication and related exams are provided at no cost to you
• You will be compensated per visit for your participation
• Your child will be monitored closely by our study team to ensure safety and good health

If you would like to learn more about participating in this study, please send an e-mail message using the form below.